‘COVAXIN® Proven SAFE in India’s Largest Efficacy Trial. Final Phase-3 Pre-Print Data Published…’ -Tweet From Ocugen COVID-19 Vaccine Partner, Bharat
https://twitter.com/BharatBiotech/status/1411054740713086979
What’s Going On With Ocugen (OCGN) Stock Today?
Ocugen Inc (NASDAQ: OCGN) shares are trading 1.6% higher in the pre-market session on Wednesday amid high social media interest.
The company's shares had closed nearly 2% lower at $8.46 in the regular session, the day prior.
‘Adjuvant Developed with NIH Funding Enhances Efficacy of India’s COVID-19 Vaccine’ -NIAID Report. BZ NOTE: Occugen Is A Partner With India’s Bharat Biotech, Which Will Be Providing Many Of The Nation’s COVID-19 Vaccines
https://www.niaid.nih.gov/news-events/adjuvant-developed-nih-funding-enhances-efficacy-indias-covid-19-vaccine
Top 20 Trending Stocks On WallStreetBets As Of Friday, June 25, 2021 (Via Swaggy Stocks)
Data from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment
Tesla (TSLA)
ContextLogic (WISH)
Clover Health Investments (CLOV)
Paysafe (PSFE)
Workhorse Group (WKHS)
AMC Entertainment
What’s Next For Ocugen Stock As It Bounces Off Support?
Ocugen Inc. (NASDAQ: OCGN) shares are trading lower Tuesday, likely making a correction after shares saw a nice gain Monday.
Ocugen was down 5.14% at $7.02 at last check.
Ocugen Shares Quiet; Traders Circulate ANI Article Titled ‘Bharat Biotech’s Covaxin shows 77.8 pc efficacy in Phase III trials, say sources’
https://aninews.in/news/national/general-news/bharat-biotechs-covaxin-shows-778-pc-efficacy-in-phase-iii-trials-say-sources20210622154048/
Ocugen Shares Up 9% Following Earlier Report ‘Bharat Biotech submitted Phase 3 clinical trials data of COVAXIN to Drugs Controller General of India (DCGI) over the weekend: Govt sources’
https://twitter.com/ANI/status/1407012119095087106?s=20
Ocugen Inc. Set to Join Russell 3000 Index
Ocugen, Inc. (NASDAQ:OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today
24 Stocks Moving in Wednday’s Pre-Market Session
Gainers
Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB) rose 43.6% to $2.93 in pre-market trading after a 13G filing from Ra Capital showed a 7.5% stake in the company.